381 results on '"Martinotti,Giovanni"'
Search Results
2. New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances
3. Rethinking Mental Automatism: De Clérambault’s Theory in the Age of Novel Psychoactive Drugs: Psychotropic Effects and Synthetic Psychosis
4. The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances
5. Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation
6. 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report
7. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial
8. Unraveling the Link Between Complex Post-traumatic Stress Symptoms and Addictive Behaviors in Adolescents: A Network Analysis
9. Connected minds in disconnected bodies: Exploring the role of interoceptive sensibility and alexithymia in problematic use of the internet
10. Investigating the Effectiveness of Brexpiprazole in Schizophrenic Patients with Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Study
11. Editorial: Comorbidity in bipolar disorder and schizophrenia, volume III
12. Aberrant salience in cannabis-induced psychosis: a comparative study
13. Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder
14. The interplay between mentalization, personality traits and burnout in psychiatry training: Results from a large multicenter controlled study
15. Exploring the potential of Esketamine in the treatment of bipolar depression
16. The association between traumatic experiences and substance and behavioral addictions in late adolescence: A role for PTSD and cPTSD as potential mediators
17. Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group
18. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
19. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
20. Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature
21. Rethinking ‘Innovation’ in Psychiatry with Older and Newer Treatments: From Bench to Benchside
22. A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia
23. GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
24. Intranasal esketamine as tool for Rapid Cycling Bipolar Disorder: a case report of successful mood stabilization
25. Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia
26. LSD-induced changes in the functional connectivity of distinct thalamic nuclei
27. Staying connected: An umbrella review of meta-analyses on the push-and-pull of social connection in depression
28. Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals
29. Repetitive Transcranial Magnetic Stimulation in Addiction
30. Transcranial Direct Current Stimulation in Addiction
31. Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration-FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
32. Predictors of polysubstance use in patients with severe alcohol use disorder: the role of reward craving
33. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
34. Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)]
35. Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
36. Neurotrophic Factors In Cannabis-Induced Psychosis: An Update
37. MDMA-Based Psychotherapy in Treatment-Resistant Post-traumatic Stress Disorder (PTSD): A Brief Overview of Current Evidence
38. Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study
39. Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
40. Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine
41. Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study
42. Beyond the efficacy of Transcranial Magnetic Stimulation in Peripartum Depression: A systematic review exploring perinatal safety for newborns
43. Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
44. Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions
45. Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
46. When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia
47. Novel and Traditional Club Substances’ Association to Psychopathological and Medical Sequelae
48. Sexual Dysfunctions and Substance-Related and Addictive Disorders
49. Lorcaserin: worthy of further insights? Results from recent research
50. Functional Neurologic Disorders, disorders to be managed by neurologists, or are neurologists wandering in a dangerous field with inadequate resources?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.